Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG 4000 vs PEG 3350+Electrolytes for Fecal Disimpaction in Pediatric Functional Constipation
NCT06349031Phase 4Not yet recruiting
- Sponsor
- Institute of Medical Sciences and SUM Hospital
- Start
- Apr 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of macrogol 4000 in functional constipation (FC), fecal impaction, sponsored by Institute of Medical Sciences and SUM Hospital. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
macrogol 4000
03
Conditions
functional constipation (FC)fecal impaction
Beyond the preview
Go deeper on NCT06349031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06349031.